Skip to contentCormorant Asset Management, LP — Erasca, Inc. insider: 53 transactions · InsiderLensCormorant Asset Management, LP
- (See below) at ENVIVIO INC · on record since Jun 8, 2023
- 10% owner at pSivida LTD · on record since Dec 12, 2023
- 10% owner at MoonLake Immunotherapeutics · on record since Oct 10, 2023
- 10% owner at Corbus Pharmaceuticals Holdings, Inc. · on record since Jan 30, 2024
- 10% owner at BioAge Labs, Inc. · on record since Sep 25, 2024
- 10% owner at DRAGON PHARMACEUTICAL INC · on record since Oct 17, 2024
- 10% owner at OnKure Therapeutics, Inc. · on record since Oct 15, 2024
- Former 10% Owner at BioAge Labs, Inc. · on record since Oct 1, 2024
- Former 10% Owner at ACROSS AMERICA REAL ESTATE CORP · on record since Feb 19, 2025
- 10% owner at ACROSS AMERICA REAL ESTATE CORP · on record since Feb 12, 2025
- Former 10% Owner at OnKure Therapeutics, Inc. · on record since May 19, 2025
- Former 10% Holder at Biomea Fusion, Inc. · on record since Aug 1, 2025
- Former 10% Owner at pSivida LTD · on record since Dec 8, 2025
- Former 10% Owner at MoonLake Immunotherapeutics · on record since Oct 1, 2025
- 10% owner at HIGHLAND BUSINESS SERVICES, INC. · on record since Jun 24, 2021
- 10% owner at Monte Rosa Therapeutics, Inc. · on record since Jun 23, 2021
- Former 10% Owner at Verve Therapeutics, Inc. · on record since Jun 23, 2021
- 10% owner at Tyra Biosciences, Inc. · on record since Sep 14, 2021
- 10% owner at Biomea Fusion, Inc. · on record since Apr 22, 2021
- 10% owner at Rain Enhancement Technologies Holdco, Inc. · on record since Apr 22, 2021
- Former 10% Owner at DRAGON PHARMACEUTICAL INC · on record since Apr 30, 2026
- Director at Biomea Fusion, Inc. · on record since Apr 19, 2021
- 10% owner at PERFORMANCE TECHNOLOGIES INC \DE\ · on record since Nov 23, 2016
- 10% owner at Verve Therapeutics, Inc. · on record since Jun 16, 2021
- 10% owner at Cellectar Biosciences, Inc. · on record since Sep 5, 2014
- 10% owner at Clearside Biomedical, Inc. · on record since Jun 13, 2016
- 10% owner at Apellis Pharmaceuticals, Inc. · on record since Nov 14, 2017
- 10% owner at Kiniksa Pharmaceuticals International, plc · on record since May 31, 2018
- 10% owner at Kezar Life Sciences, Inc. · on record since Jun 27, 2018
- 10% owner at CONSTAR INTERNATIONAL INC · on record since Jul 20, 2018
- 10% owner at Axonics Modulation Technologies, Inc. · on record since Oct 30, 2018
- Former 10% Owner at Design Therapeutics, Inc. · on record since Apr 1, 2021
- 10% owner at AXONYX INC · on record since Apr 25, 2019
- Former 10% Owner at AXONYX INC · on record since Aug 12, 2019
- 10% owner at Akouos, Inc. · on record since Jun 25, 2020
- Former 10% Owner at Atrium Therapeutics, Inc. · on record since Jun 18, 2020
- 10% owner at Atrium Therapeutics, Inc. · on record since Jun 11, 2020
- 10% owner at IMARX THERAPEUTICS INC · on record since Jul 29, 2021
- Former 10% Owner at Akouos, Inc. · on record since Jul 2, 2020
- 10% owner at Atea Pharmaceuticals, Inc. · on record since Oct 29, 2020
- Former 10% Owner at Olema Pharmaceuticals, Inc. · on record since Nov 23, 2020
- Former 10% Owner at BioAtla, Inc. · on record since Dec 22, 2020
- 10% owner at Olema Pharmaceuticals, Inc. · on record since Nov 18, 2020
- 10% owner at BioAtla, Inc. · on record since Dec 15, 2020
- Former 10% Owner at Atea Pharmaceuticals, Inc. · on record since Nov 5, 2020
- 10% owner at Design Therapeutics, Inc. · on record since Mar 25, 2021
- 10% owner at Ignyta, Inc. · on record since Mar 18, 2021
- Former 10% Owner at Ignyta, Inc. · on record since Mar 18, 2021
- Former 10% Owner at Monte Rosa Therapeutics, Inc. · on record since Jun 30, 2021
- 10% owner at Jade Biosciences, Inc. · on record since Jun 29, 2021
- Former 10% Owner at Rain Enhancement Technologies Holdco, Inc. · on record since Apr 29, 2021
- 10% owner at Icosavax, Inc. · on record since Jul 28, 2021
- 10% owner at Erasca, Inc. · on record since Jul 22, 2021
- Former 10% Owner at Tyra Biosciences, Inc. · on record since Sep 21, 2021
- Former 10% Owner at Jade Biosciences, Inc. · on record since Jul 7, 2021
- Former 10% Owner at IMARX THERAPEUTICS INC · on record since Aug 5, 2021
- Former 10% Owner at Icosavax, Inc. · on record since Aug 4, 2021
- Former 10% Owner at HIGHLAND BUSINESS SERVICES, INC. · on record since Jul 1, 2021
- Former 10% Owner at Ventyx Biosciences, Inc. · on record since Oct 27, 2021
- 10% owner at Ventyx Biosciences, Inc. · on record since Oct 20, 2021
- Former 10% Owner at Pyxis Oncology, Inc. · on record since Oct 15, 2021
- 10% owner at Pyxis Oncology, Inc. · on record since Oct 7, 2021
- Former 10% Owner at Vigil Neuroscience, Inc. · on record since Jan 13, 2022
- 10% owner at Vigil Neuroscience, Inc. · on record since Jan 6, 2022
- Director at Erasca, Inc. · on record since Dec 21, 2022
- 10% owner at Ambrx Biopharma Inc. · on record since Mar 16, 2023
Insider trading activity of Cormorant Asset Management, LP
- Transactions on record
- 53
- since Nov 14, 2016
- Open-market buys
- 24
- $171.8M
- Open-market sells
- 2
- $10.7M
- Companies traded
- 14
- last filing Apr 30, 2026
Figures computed from official regulatory filings — methodology.
Companies where Cormorant Asset Management, LP has traded
- DRAGON PHARMACEUTICAL INC2 tx · $13.8M · Apr 30, 2026
- pSivida LTD6 tx · $38.1M · Dec 8, 2025
- Corbus Pharmaceuticals Holdings, Inc.1 tx · $14.3M · Feb 6, 2024
- Ambrx Biopharma Inc.3 tx · $28.8M · Oct 25, 2023
- Erasca, Inc.7 tx · $19.2M · Dec 21, 2022
- Biomea Fusion, Inc.4 tx · $15.3M · Jun 24, 2022
- Pyxis Oncology, Inc.3 tx · $7.2M · Oct 15, 2021
- IMARX THERAPEUTICS INC3 tx · $8.3M · Aug 5, 2021
- Monte Rosa Therapeutics, Inc.4 tx · $11.4M · Jun 30, 2021
Track record of Cormorant Asset Management, LP
Statistical track record
Free- Open-market buys
- 24
- Last buy
- Nov 4, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Cormorant Asset Management, LP
Co-insiders of Cormorant Asset Management, LP
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
4 tx · $15M · Apr 1, 2021
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Apr 30, 2026 | Sell | -109,331 | 89.50 USD | $9.8M | SEC |
| Dec 8, 2025 | Sell | -60,000 | 15.70 USD | $942K | SEC |
| Nov 6, 2024 | Buy | 184,331 | 21.70 USD | $4M | SEC |
| May 8, 2024 | Buy | 207,153 | 12.36 USD | $2.6M | SEC |
| May 8, 2024 | Buy | 642,847 | 11.70 USD | $7.5M | SEC |
| Feb 6, 2024 | Buy | 750,000 | 19.00 USD | $14.3M | SEC |
| Jan 11, 2024 | Buy | 105,000 | 21.32 USD | $2.2M | SEC |
| Jan 11, 2024 | Buy | 750,000 | 19.75 USD | $14.8M | SEC |
| Dec 12, 2023 | Buy | 588,235 | 17.00 USD | $10M | SEC |
| Oct 25, 2023 | Buy | 1,307,311 | 6.99 USD | $9.1M | SEC |
| Sep 19, 2023 | Buy | 1,401,505 | 9.05 USD | $12.7M | SEC |
| Sep 19, 2023 | Buy | 751,233 | 9.24 USD | $6.9M | SEC |
| Dec 21, 2022 | Buy | 307,692 | 6.50 USD | $2M | SEC |
| Dec 20, 2022 | Buy | 307,692 | 6.50 USD | $2M | SEC |
| Jun 24, 2022 | AwardD | 23,867 | 0.00 USD | $0 | SEC |
| Oct 15, 2021 | OtherD | -668,854 | — | — | SEC |
| Oct 15, 2021 | Other | 668,854 | — | — | SEC |
| Oct 15, 2021 | Buy | 450,000 | 16.00 USD | $7.2M | SEC |
| Aug 5, 2021 | OtherD | -1,702,628 | — | — | SEC |
| Aug 5, 2021 | Buy | 550,000 | 15.00 USD | $8.3M | SEC |
| Aug 5, 2021 | Other | 1,702,628 | — | — | SEC |
| Jul 22, 2021 | OtherD | 4,000,000 | — | — | SEC |
| Jul 22, 2021 | Other | 9,555,553 | — | — | SEC |
| Jul 22, 2021 | OtherD | 4,166,666 | — | — | SEC |
| Jul 22, 2021 | OtherD | 1,388,887 | — | — | SEC |